Vext Science, Inc.
VEXTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 3.4% | -1.7% | -4.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 24.9% | 34.6% | 65.2% | 50.2% |
| EBITDA | -$0 | $0 | $0 | $0 |
| % Margin | -5.6% | 49.9% | 42.4% | 34.4% |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -62.3% | 12.6% | 30.8% | 13.4% |
| EPS Diluted | -0.093 | 0.027 | 0.075 | 0.034 |
| % Growth | -448.7% | -64.5% | 122.5% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |